Metraipolis › archive › dc_7a3bf1da716c

De-escalating adjuvant therapy after pathologic complete response in oral squamous cell carcinoma: Chemoradiotherapy benefits only high-risk subgroups — Europe PMC PMID:41018074

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41018074
DOI
10.3389/fonc.2025.1647606
License (as archived)
solo-consultazione
Archived
2026-11-10T00:42:32.852Z
SHA-256 of the archived text
adb2670b126bba43d3fb43fb1a97e00c67780775d435769d3547ad40451a3ade
Stable URL of this page
https://metraipolis.com/documento/dc_7a3bf1da716c

How to cite

De-escalating adjuvant therapy after pathologic complete response in oral squamous cell carcinoma: Chemoradiotherapy benefits only high-risk subgroups — Europe PMC PMID:41018074 — Europe PMC (en), https://europepmc.org/article/MED/41018074 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7a3bf1da716c (Metraipolis archive dc_7a3bf1da716c, sha256 adb2670b126bba43d3fb43fb1a97e00c67780775d435769d3547ad40451a3ade)
BibTeX
@misc{dc7a3bf1da716c,
  title = {De-escalating adjuvant therapy after pathologic complete response in oral squamous cell carcinoma: Chemoradiotherapy benefits only high-risk subgroups — Europe PMC PMID:41018074},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41018074},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7a3bf1da716c; sha256 adb2670b126bba43d3fb43fb1a97e00c67780775d435769d3547ad40451a3ade},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41018074. Agents can read the archived copy with the MCP tool read_document.